Supplementary Figure S2 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
Abstract
Figure S2. (A and B) Enrichment of LAMP2A and HSPA8: Coomassie-stained SDS-PAGE gel. (C) Western blot validation of stable LAMP2A-knockdown FaDu cell line. β-actin served as loading control. (D) BASP1, SELENBP1 and PSCA mRNA levels in human HNSCC tissues, data from the open-access database GEPIA2.
Fields of Study & Subjects
Head and Neck Cancer Studies
Autophagy in Disease and Therapy
Cellular transport and secretion
Publication details
- Publication date
- 6 February 2026